AR045724A1 - Composicion farmaceutica orodispersable de un compuesto antitrombotico - Google Patents

Composicion farmaceutica orodispersable de un compuesto antitrombotico

Info

Publication number
AR045724A1
AR045724A1 ARP040102490A ARP040102490A AR045724A1 AR 045724 A1 AR045724 A1 AR 045724A1 AR P040102490 A ARP040102490 A AR P040102490A AR P040102490 A ARP040102490 A AR P040102490A AR 045724 A1 AR045724 A1 AR 045724A1
Authority
AR
Argentina
Prior art keywords
compound
pharmaceutical composition
orodispersable
antitrombotic
pharmaceutically acceptable
Prior art date
Application number
ARP040102490A
Other languages
English (en)
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR045724A1 publication Critical patent/AR045724A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composición farmacéutica orodispersable sólida del compuesto A de fórmula (1), opcionalmente en forma de isómero óptico, o una sal farmacéuticamente aceptable del mismo, caracterizada porque comprende: el compuesto A o una sal farmacéuticamente aceptable del mismo; gránulos compuestos por lactosa y almidón codeshidratados.
ARP040102490A 2003-07-18 2004-07-15 Composicion farmaceutica orodispersable de un compuesto antitrombotico AR045724A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0308780A FR2857593B1 (fr) 2003-07-18 2003-07-18 Composition pharmaceutique orodispersible d'un compose antithrombotique

Publications (1)

Publication Number Publication Date
AR045724A1 true AR045724A1 (es) 2005-11-09

Family

ID=33548240

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102490A AR045724A1 (es) 2003-07-18 2004-07-15 Composicion farmaceutica orodispersable de un compuesto antitrombotico

Country Status (28)

Country Link
US (1) US20060167100A1 (es)
EP (1) EP1646373B1 (es)
JP (1) JP2006528160A (es)
KR (1) KR100762598B1 (es)
CN (1) CN100544709C (es)
AR (1) AR045724A1 (es)
AT (1) ATE409032T1 (es)
AU (1) AU2004258713B2 (es)
BR (1) BRPI0412706A (es)
CA (1) CA2532608A1 (es)
DE (1) DE602004016751D1 (es)
DK (1) DK1646373T3 (es)
EA (1) EA010372B1 (es)
ES (1) ES2314440T3 (es)
FR (1) FR2857593B1 (es)
GE (1) GEP20094649B (es)
HK (1) HK1094152A1 (es)
HR (1) HRP20080521T3 (es)
MA (1) MA27891A1 (es)
MX (1) MXPA06000712A (es)
MY (1) MY138799A (es)
NO (1) NO20060803L (es)
PL (1) PL1646373T3 (es)
PT (1) PT1646373E (es)
SI (1) SI1646373T1 (es)
UA (1) UA79567C2 (es)
WO (1) WO2005009428A2 (es)
ZA (1) ZA200600241B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2899473B1 (fr) * 2006-04-07 2008-06-13 Servier Lab Utilisation d'un compose anti-atherothrombotique pour l'obtention de medicaments destines au traitement des troubles vasculaires
JP2010526744A (ja) 2007-05-11 2010-08-05 オーチス エレベータ カンパニー 所期の耐用期間に基づいた初期安全係数を有するエレベータ耐荷重アセンブリ
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine
US8307129B2 (en) * 2008-01-14 2012-11-06 International Business Machines Corporation Methods and computer program products for swapping synchronous replication secondaries from a subchannel set other than zero to subchannel set zero using dynamic I/O
US7761610B2 (en) * 2008-01-25 2010-07-20 International Business Machines Corporation Methods and computer program products for defining synchronous replication devices in a subchannel set other than subchannel set zero
US8516173B2 (en) * 2008-07-28 2013-08-20 International Business Machines Corporation Swapping PPRC secondaries from a subchannel set other than zero to subchannel set zero using control block field manipulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US6171616B1 (en) * 1998-04-13 2001-01-09 Shin-Etsu Chemical Co., Ltd. Solid preparation and a method of manufacturing it
DE60036205T2 (de) * 2000-07-27 2008-05-21 Roquette Frères Granulat bestehend aus Stärke und Laktose

Also Published As

Publication number Publication date
NO20060803L (no) 2006-02-17
EP1646373A2 (fr) 2006-04-19
WO2005009428A2 (fr) 2005-02-03
KR20060031688A (ko) 2006-04-12
BRPI0412706A (pt) 2006-09-26
DK1646373T3 (da) 2008-12-15
EA010372B1 (ru) 2008-08-29
EA200600173A1 (ru) 2006-08-25
CN1819823A (zh) 2006-08-16
FR2857593B1 (fr) 2005-10-14
ZA200600241B (en) 2007-04-25
PL1646373T3 (pl) 2009-02-27
FR2857593A1 (fr) 2005-01-21
HK1094152A1 (en) 2007-03-23
AU2004258713A1 (en) 2005-02-03
HRP20080521T3 (en) 2009-01-31
JP2006528160A (ja) 2006-12-14
ATE409032T1 (de) 2008-10-15
KR100762598B1 (ko) 2007-10-04
CA2532608A1 (fr) 2005-02-03
MXPA06000712A (es) 2006-04-11
WO2005009428A3 (fr) 2005-04-07
US20060167100A1 (en) 2006-07-27
AU2004258713B2 (en) 2007-07-12
DE602004016751D1 (de) 2008-11-06
CN100544709C (zh) 2009-09-30
PT1646373E (pt) 2008-11-13
MA27891A1 (fr) 2006-05-02
UA79567C2 (en) 2007-06-25
GEP20094649B (en) 2009-03-25
EP1646373B1 (fr) 2008-09-24
ES2314440T3 (es) 2009-03-16
MY138799A (en) 2009-07-31
SI1646373T1 (sl) 2009-02-28

Similar Documents

Publication Publication Date Title
ECSP034456A (es) Analogos de somatostatina
RS52274B (en) UNIT DIARYLHIDANTOIN
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
ATE456368T1 (de) Reboxetin enthaltende tablette mit verzögerter wirkstoffabgabe
ECSP044992A (es) Inhibidores de la alquín-aril fosfodiesterasa-4
NO2014009I2 (no) Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser
ECSP066753A (es) Antagonistas del receptor de quimiocina
ZA200801171B (en) 3, IIB-CIS-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation
DE60312049D1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
WO2005007137A3 (de) Ambroxolhaltige tabletten
JP2005509503A5 (es)
ATE389392T1 (de) Paracetamol enthaltende tablette
AR056517A1 (es) Composiciones y metodos farmaceuticos utilizando temozolomida y un inhibidor de la proteina quinasa
AR045724A1 (es) Composicion farmaceutica orodispersable de un compuesto antitrombotico
EA200400884A1 (ru) Диспергируемая во рту фармацевтическая композиция периндоприла
EA200600953A1 (ru) Дозированные формы торсемида пролонгированного высвобождения
DE602004014991D1 (de) Pharmazeutische zusammensetzung mit einem nicht-detergens sulfobetain
AR043016A2 (es) Un compuesto antimigranico eletriptan y composicion farmaceutica que lo contiene
NO20074439L (no) Benzoksazokiner og deres terapeutiske anvendelse
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12
AR039253A1 (es) Asociacion de un antitrombotico y de aspirina
NL1023797A1 (nl) Farmaceutische doseringsvorm die zwangerschapsvriendelijke onderscheidingstekens draagt.
ECSP045295A (es) Composiciones farmacéuticas que comprenden 2-(4-etoxi-fenil)-3-(4-metanosulfonil-fenil)-pirazolo'1,5-bipiridacina en forma nanoparticulada
RU2001109481A (ru) Антиангинальное средство
UY27122A1 (es) Una composición farmacéutica que comprende de 2 a 4 mg de 5-(a-(2-(n-metil-n-(2-piridil)amino)etoxi)bencil)tiazolidin-2,4-diona

Legal Events

Date Code Title Description
FB Suspension of granting procedure